Key Points
-
The contribution of different nicotinic acetylcholine (ACh) receptor (nAChR) oligomers to nicotine addiction is being explored in mice, using novel strategies including deletion of nAChR subunit genes or targeted knock-in gene mutations; re-expression of a deleted gene using stereotaxic injection of a lentiviral vector carrying the missing gene; repression of a wild-type gene using stereotaxic injection of the relevant small interfering RNA; and the quantitative analysis of the neuronal firing patterns and the behaviours elicited by nicotine in these mice.
-
Spontaneous locomotor and cognitive behaviour is under the control of α4-containing (α4*), α6* and β2*nAChR activation by endogenous ACh, with a possible contribution of the β3 subunit.
-
α4*, β2* and α6*nAChRs mediate the rewarding effects of nicotine, with a possible contribution of the α7 subunit.
-
In addition to the β2 subunit, the α4 subunit (but not the α6 subunit) is required for the transition from tonic to phasic firing of dopaminergic neurons in the ventral tegmental area (VTA) that is crucial for reinforcement.
-
α4 and α6 subunits are necessary for efficient dopamine release in the nucleus accumbens.
-
There is evidence that, through activation of α4β2* and α7*nAChRs, acute nicotine exposure influences a global 'gating' circuit that includes the striatum, hippocampus and amygdala and is under top-down control of the prefrontal cortex.
-
Several mechanisms may account for the sensitization of dopaminergic neurons in the VTA that occurs during long-term exposure to nicotine, including upregulation of nAChR expression, presynaptic compensation by α7-mediated cholinergic transmission, and a top-down increase in bursting activity of dopamine neuron activity in the VTA.
-
Nicotine withdrawal syndromes mobilize brain circuits that are distinct from those involved in reward processing, with α2, α5, α6, α7 and β4 nAChR subunits regulating the expression of somatic symptoms, and β2 and α6 subunits contributing to affective symptoms.
Abstract
The past decades have seen a revolution in our understanding of brain diseases and in particular of drug addiction. This has been largely due to the identification of neurotransmitter receptors and the development of animal models, which together have enabled the investigation of brain functions from the molecular to the cognitive level. Tobacco smoking, the principal — yet avoidable — cause of lung cancer is associated with nicotine addiction. Recent studies in mice involving deletion and replacement of nicotinic acetylcholine receptor subunits have begun to identify the molecular mechanisms underlying nicotine addiction and might offer new therapeutic strategies to treat this addiction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dome, P. et al. Smoking, nicotine and neuropsychiatric disorders. Neurosci. Biobehav. Rev. 34, 295–342 (2009).
Stead, L. F., Perera, R., Bullen, C., Mant, D. & Lancaster, T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 1, CD000146 (2008).
Changeux, J. P. & Edelstein, S. J. Nicotinic Acetylcholine Receptors: From Molecular Biology to Cognition (Odile Jacob, New York, 2005).
Taly, A., Corringer, P. J., Guedin, D., Lestage, P. & Changeux, J. P. Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nature Rev. Drug Discov. 8, 733–750 (2009). A recent review on nicotinic drugs that are in development for the treatment of brain diseases.
Picciotto, M. R. et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374, 65–67 (1995).
Greenbaum, L. & Lerer, B. Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions. Mol. Psychiatry 14, 912–945 (2009).
Orr-Urtreger, A. et al. W. Mice homozygous for the L250T mutation in the α7 nicotinic acetylcholine receptor show increased neuronal apoptosis and die within 1 day of birth. J. Neurochem. 74, 2154–2166 (2000).
Tapper, A. R. et al. Nicotine activation of α4* receptors: sufficient for reward, tolerance, and sensitization. Science 306, 1029–1032 (2004).
King, S. L. et al. Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior. J. Neurosci. 23, 3837–3843 (2003).
Maskos, U. et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436, 103–107 (2005). An efficient method of nAChR subunit gene re-expression using lentiviral vectors.
Avale, M. E. et al. Interplay of β2* nicotinic receptors and dopamine pathways in the control of spontaneous locomotion. Proc. Natl Acad. Sci. USA 105, 15991–15996 (2008).
Le Novere, N. et al. Involvement of α6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion. Neuroreport 10, 2497–2501 (1999).
Mameli-Engvall, M. et al. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50, 911–921 (2006).
Maubourguet, N., Lesne, A., Changeux, J. P., Maskos, U. & Faure, P. Behavioral sequence analysis reveals a novel role for β2* nicotinic receptors in exploration. PLoS Comput. Biol. 4, e1000229 (2008).
Gotti, C. et al. Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem. Pharmacol. 78, 703–711 (2009).
Katz, B. & Thesleff, S. A study of the desensitization produced by acetylcholine at the motor end-plate. J. Physiol. 138, 63–80 (1957).
Govind, A. P., Vezina, P. & Green, W. N. Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem. Pharmacol. 78, 756–765 (2009).
Koob, G. F. A role for brain stress systems in addiction. Neuron 59, 11–34 (2008).
Davis, J. A. & Gould, T. J. Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits. Eur. Neuropsychopharmacol. 19, 551–561 (2009).
Salas, R., Sturm, R., Boulter, J. & De Biasi, M. Nicotinic receptors in the habenula-interpeduncular system are necessary for nicotine withdrawal in mice. J. Neurosci. 29, 3014–3018 (2009). This study provides evidence for a role of the habenulo–interpeduncular system in nicotine withdrawal.
Naqvi, N. H. & Bechara, A. The hidden island of addiction: the insula. Trends Neurosci. 32, 56–67 (2009).
Suarez, S. V. et al. Brain activation by short-term nicotine exposure in anesthetized wild-type and β2-nicotinic receptors knockout mice: a BOLD fMRI study. Psychopharmacology (Berl.) 202, 599–610 (2009).
Everitt, B. J. & Robbins, T. W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature Neurosci. 8, 1481–1489 (2005).
Koob, G. F. & Le Moal, M. Neurobiological mechanisms for opponent motivational processes in addiction. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363, 3113–3123 (2008).
Kenny, P. J. & Markou, A. Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 31, 1203–1211 (2006).
Gutkin, B. S., Dehaene, S. & Changeux, J. P. A neurocomputational hypothesis for nicotine addiction. Proc. Natl Acad. Sci. USA 103, 1106–1111 (2006).
Balfour, D. J. The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens. Nicotine Tob. Res. 6, 899–912 (2004).
Newhouse, P. A., Potter, A. & Singh, A. Effects of nicotinic stimulation on cognitive performance. Curr. Opin. Pharmacol. 4, 36–46 (2004).
Levin, E. D. Nicotinic receptor subtypes and cognitive function. J. Neurobiol. 53, 633–640 (2002).
Stolerman, I. P., Garcha, H. S. & Mirza, N. R. Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology (Berl.) 117, 430–437 (1995).
Poorthuis, R. B., Goriounova, N. A., Couey, J. J. & Mansvelder, H. D. Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences. Biochem. Pharmacol. 78, 668–676 (2009).
Caldarone, B. J., Duman, C. H. & Picciotto, M. R. Fear conditioning and latent inhibition in mice lacking the high affinity subclass of nicotinic acetylcholine receptors in the brain. Neuropharmacology 39, 2779–2784 (2000).
Granon, S., Faure, P. & Changeux, J. P. Executive and social behaviors under nicotinic receptor regulation. Proc. Natl Acad. Sci. USA 100, 9596–9601 (2003).
Marubio, L. M. et al. Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. Eur. J. Neurosci. 17, 1329–1337 (2003).
Labarca, C. et al. Point mutant mice with hypersensitive α4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proc. Natl Acad. Sci. USA 98, 2786–2791 (2001).
Cui, C. et al. The β3 nicotinic receptor subunit: a component of αl-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. J. Neurosci. 23, 11045–11053 (2003).
Salas, R., Cook, K. D., Bassetto, L. & De Biasi, M. The α3 and β4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice. Neuropharmacology 47, 401–407 (2004).
Fernandes, C., Hoyle, E., Dempster, E., Schalkwyk, L. C. & Collier, D. A. Performance deficit of α7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory. Genes Brain Behav. 5, 433–440 (2006). An elegant demonstration of the contribution of the α7 nAChR subunit to working memory.
Paylor, R. et al. α7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn. Mem. 5, 302–316 (1998).
McGaugh, J. L., McIntyre, C. K. & Power, A. E. Amygdala modulation of memory consolidation: interaction with other brain systems. Neurobiol. Learn. Mem. 78, 539–552 (2002).
Young, J. W. et al. Nicotine improves sustained attention in mice: evidence for involvement of the α7 nicotinic acetylcholine receptor. Neuropsychopharmacology 29, 891–900 (2004).
Marubio, L. M. & Paylor, R. Impaired passive avoidance learning in mice lacking central neuronal nicotinic acetylcholine receptors. Neuroscience 129, 575–582 (2004).
Corrigall, W. Nicotine self-administration in animals as a dependence model. Nicotine Tob. Res. 1, 11–20 (1999).
Pons, S. et al. Crucial role of α4 and α6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J. Neurosci. 28, 12318–12327 (2008).
David, V., Besson, M., Changeux, J. P., Granon, S. & Cazala, P. Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors. Neuropharmacology 50, 1030–1040 (2006).
Picciotto, M. R. et al. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173–177 (1998).
Epping-Jordan, M. P., Picciotto, M. R., Changeux, J. P. & Pich, E. M. Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice. Psychopharmacology (Berl.) 147, 25–26 (1999).
Frahm, S. et al. The acetylcholine receptor β4-subunit is rate limiting for nicotinic function in vivo. Society for Neuroscience Annual Meeting (Chicago, Illinois) Abstract 228.13 (2009).
Fowler, C. D. & Kenny, P. J. Intravenous nicotine self-administration in wild type and α5 nicotinic acetylcholine receptor subunit knock-out mice. Society for Neuroscience Annual Meeting (Chicago, Illinois) Abstract 447.15 (2009).
Klink, R., de Kerchove d'Exaerde, A., Zoli, M. & Changeux, J. P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 21, 1452–1463 (2001).
Walters, C. L., Brown, S., Changeux, J. P., Martin, B. & Damaj, M. I. The β2 but not α7 subunit of the nicotinic acetylcholine receptor is required for nicotine conditioned place preference in mice. Psychopharmacology (Berl.) 184, 339–344 (2006).
Stolerman, I. P., Chamberlain, S., Bizarro, L., Fernandes, C. & Schalkwyk, L. The role of nicotinic receptor α 7 subunits in nicotine discrimination. Neuropharmacology 46, 363–371 (2004).
Jackson, K. J., McIntosh, J. M., Brunzell, D. H., Sanjakdar, S. S. & Damaj, M. I. The role of α6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal. J. Pharmacol. Exp. Ther. 331, 547–554 (2009).
Levin, E. D. et al. Nicotinic α7- or β2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice. Behav. Brain Res. 196, 207–213 (2009). This study demonstrates the long-term consequences of nAChR subunit gene deletion on mouse behaviour.
Balfour, D. J., Benwell, M. E., Birrell, C. E., Kelly, R. J. & Al-Aloul, M. Sensitization of the mesoaccumbens dopamine response to nicotine. Pharmacol. Biochem. Behav. 59, 1021–1030 (1998).
Watkins, S. S., Koob, G. F. & Markou, A. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob. Res. 2, 19–37 (2000).
Overton, P. G. & Clark, D. Burst firing in midbrain dopaminergic neurons. Brain Res. Brain Res. Rev. 25, 312–334 (1997).
Kitai, S. T., Shepard, P. D., Callaway, J. C. & Scroggs, R. Afferent modulation of dopamine neuron firing patterns. Curr. Opin. Neurobiol. 9, 690–697 (1999).
Grace, A. A. & Bunney, B. S. The control of firing pattern in nigral dopamine neurons J. Neurosci. 4, 2866–2876 (1984).
Chergui, K., Nomikos, G. G., Mathe, J. M., Gonon, F. & Svensson, T. H. Burst stimulation of the medial forebrain bundle selectively increase Fos-like immunoreactivity in the limbic forebrain of the rat. Neuroscience 72, 141–156 (1996).
Chergui, K. et al. Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle. Eur. J. Neurosci. 9, 2370–2382 (1997).
Schultz, W. Getting formal with dopamine and reward. Neuron 36, 241–263, (2002).
Mansvelder, H. D., De Rover, M., McGehee, D. S. & Brussaard, A. B. Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction. Eur. J. Pharmacol. 480, 117–123 (2003).
Floresco, S. B., West, A. R., Ash, B., Moore, H. & Grace, A. A. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nature Neurosci. 6, 968–973 (2003).
Lodge, D. J. & Grace, A. A. The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology 31, 1356–1361 (2006).
Faure, P. et al. Differential role for α4 and α6 nicotinic subunit in burst response to nicotine in dopamine neurons. FENS Forum of European Neuroscience (Amsterdam, the Netherlands) Abstract P14006 (2010).
Rice, M. E. & Cragg, S. J. Nicotine amplifies reward-related dopamine signals in striatum. Nature Neurosci. 7, 583–584 (2004).
Zhang, H. & Sulzer, D. Frequency-dependent modulation of dopamine release by nicotine. Nature Neurosci. 7, 581–582 (2004).
Zhou, F. M., Liang, Y. & Dani, J. A. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nature Neurosci. 4, 1224–1229 (2001).
Exley, R., Clements, M. A., Hartung, H., McIntosh, J. M. & Cragg, S. J. α6- containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology 33, 2158–2166 (2008).
Cragg, S. J. Meaningful silences: how dopamine listens to the ACh pause. Trends Neurosci. 29, 125–131 (2006).
Zhang, T. et al. Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine. J. Neurosci. 29, 4035–4043 (2009).
Mansvelder, H. D., Keath, J. R. & McGehee, D. S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33, 905–919 (2002).
Tolu, S. et al. A versatile system for the neuronal subtype specific expression of lentiviral vectors. FASEB J. 24, 723–730 (2010). An in vivo method to distinguish the contribution of nAChRs expressed in dopaminergic versus GABAergic neurons.
Tolu, S. et al. A versatile system for the neuronal subtype specific expression of lentiviral vectors. FENS Forum of European Neuroscience (Amsterdam, the Netherlands). Abstract 07549 (2010).
Levin, E. D., McClernon, F. J. & Rezvani, A. H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl.) 184, 523–539 (2006).
Parikh, V. & Sarter, M. Cholinergic mediation of attention: contributions of phasic and tonic increases in prefrontal cholinergic activity. Ann. NY Acad. Sci. 1129, 225–235 (2008).
Orr-Urtreger, A. et al. Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci. 17, 9165–9171 (1997).
Vidal, C. & Changeux, J. P. Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro. Neuroscience 56, 23–32 (1993).
Lambe, E. K., Picciotto, M. R. & Aghajanian, G. K. Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology 28, 216–225 (2003).
Couey, J. J. et al. Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex. Neuron 54, 73–87 (2007).
Grace, A. A. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res. Brain Res. Rev. 31, 330–341 (2000).
Belujon, P. & Grace, A. A. Critical role of the prefrontal cortex in the regulation of hippocampus-accumbens information flow. J. Neurosci. 28, 9797–9805 (2008).
Placzek, A. N., Zhang, T. A. & Dani, J. A. Nicotinic mechanisms influencing synaptic plasticity in the hippocampus. Acta Pharmacol. Sin. 30, 752–760 (2009).
Matsuyama, S., Matsumoto, A., Enomoto, T. & Nishizaki, T. Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus. Eur. J. Neurosci. 12, 3741–3747 (2000).
Nashmi, R. et al. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J. Neurosci. 27, 8202–8218 (2007).
Maggi, L., Le Magueresse, C., Changeux, J. P. & Cherubini, E. Nicotine activates immature ''silent'' connections in the developing hippocampus. Proc. Natl Acad. Sci. USA 100, 2059–2064 (2003).
Le Magueresse, C., Safiulina, V., Changeux, J. P. & Cherubini, E. Nicotinic modulation of network and synaptic transmission in the immature hippocampus investigated with genetically modified mice. J. Physiol. 576, 533–546 (2006).
Tang, J. & Dani, J. A. Dopamine enables in vivo synaptic plasticity associated with the addictive drug nicotine. Neuron 63, 673–682 (2009). An in vivo electrophysiological exploration of nicotine-induced reward responses.
Wada, E. et al. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284, 314–335 (1989).
Ishii, K., Wong, J. K. & Sumikawa, K. Comparison of α2 nicotinic acetylcholine receptor subunit mRNA expression in the central nervous system of rats and mice. J. Comp. Neurol. 493, 241–260 (2005).
Jia, Y., Yamazaki, Y., Nakauchi, S. & Sumikawa, K. α2 nicotine receptors function as a molecular switch to continuously excite a subset of interneurons in rat hippocampal circuits. Eur. J. Neurosci. 29, 1588–1603 (2009).
Marshall, S. P., Adhikari, A., Nason, M. W., Role, L. & Gordon, J. A. Altered theta and gamma activity profiles in the ventral hippocampal-accumbal pathway of Type III neuregulin 1 heterozygous mice. Society for Neuroscience Annual Meeting (Chicago, Illinois) Abstract 102.9 (2009).
Zhong, C. et al. Presynaptic type III neuregulin 1 is required for sustained enhancement of hippocampal transmission by nicotine and for axonal targeting of α7 nicotinic acetylcholine receptors. J. Neurosci. 28, 9111–9116 (2008).
Hill, J. A. Jr, Zoli, M., Bourgeois, J. & Changeux, J. P. Immunocytochemical localization of a neuronal nicotinic receptor: the β2-subunit. J. Neurosci. 13, 1551–1568 (1993).
Seguela, P., Wadiche, J., Dineley-Miller, K., Dani, J. A. & Patrick, J. W. Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13, 596–604 (1993).
Jiang, L. & Role, L. W. Facilitation of cortico-amygdala synapses by nicotine: activity-dependent modulation of glutamatergic transmission. J. Neurophysiol. 99, 1988–1999 (2008).
Benwell, M. E., Balfour, D. J. & Birrell, C. E. Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine. Br. J. Pharmacol. 114, 454–460 (1995).
Schoffelmeer, A. N., De Vries, T. J., Wardeh, G., van de Ven, H. W. & Vanderschuren, L. J. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J. Neurosci. 22, 3269–3276 (2002).
Vezina, P. Sensitization, drug addiction and psychopathology in animals and humans. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 1553–1555 (2007).
Caille, S., Guillem, K., Cador, M., Manzoni, O. & Georges, F. Voluntary nicotine consumption triggers in vivo potentiation of cortical excitatory drives to midbrain dopaminergic neurons. J. Neurosci. 29, 10410–10415 (2009). An in vivo analysis of the top-down regulation of short-term to long-term nicotine consumption in the rat.
Nashmi, R. & Lester, H. Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation. Biochem. Pharmacol. 74, 1145–1154 (2007).
Marks, M. J., Burch, J. B. & Collins, A. C. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J. Pharmacol. Exp. Ther. 226, 817–825 (1983).
Sallette, J. et al. An extracellular protein microdomain controls up-regulation of neuronal nicotinic acetylcholine receptors by nicotine. J. Biol. Chem. 279, 18767–18775 (2004).
Sallette, J. et al. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46, 595–607 (2005).
Baker, L. K. et al. Nicotine upregulates VTA nAChRs and requires these receptors to induce locomotor sensitization. Society for Neuroscience Annual Meeting (Washington, DC) Abstract 1027.17 (2005).
Picciotto, M. R. Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol. Sci. 24, 493–499 (2003).
Vezina, P., McGehee, D. S. & Green, W. N. Exposure to nicotine and sensitization of nicotine-induced behaviors. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 1625–1638 (2007).
Besson, M. et al. Long-term effects of chronic nicotine exposure on brain nicotinic receptors. Proc. Natl Acad. Sci. USA 104, 8155–8160 (2007).
Koob, G. & Bloom, F. Cellular and molecular mechanisms of drug dependence. Science 242, 715–723 (1988).
Zweifel, L. S. et al. Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior. Proc. Natl Acad. Sci. USA 106, 7281–7288 (2009).
West, R. J., Hajek, P. & Belcher, M. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol. Med. 19, 981–985 (1989).
Jackson, K. J., Martin, B. R., Changeux, J. P. & Damaj, M. I. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J. Pharmacol. Exp. Ther. 325, 302–312 (2008). This study shows the role of non-classical nAChR subunits in withdrawal symptoms.
Johnson, P. M., Hollander, J. A. & Kenny, P. J. Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial selfstimulation (ICSS) studies. Pharmacol. Biochem. Behav. 90, 409–415 (2008).
Damaj, M. I., Meyer, E. M. & Martin, B. R. The antinociceptive effects of α7 nicotinic agonists in an acute pain model. Neuropharmacology 39, 2785–2791 (2000).
Salas, R., Pieri, F. & De Biasi, M. Decreased signs of nicotine withdrawal in mice null for the β4 nicotinic acetylcholine receptor subunit. J. Neurosci. 24, 10035–10039 (2004).
Salas, R., Main, A., Gangitano, D. & De Biasi, M. Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the α7 nicotinic acetylcholine receptor subunit. Neuropharmacology 53, 863–869 (2007).
Besson, M. et al. Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome. Psychopharmacology (Berl.) 187, 189–199 (2006).
Salas, R. et al. Nicotine relieves anxiogenic-like behavior in mice that overexpress the read-through variant of acetylcholinesterase but not in wild-type mice. Mol. Pharmacol. 74, 1641–1648 (2008).
Portugal, G. S., Kenney, J. W. & Gould, T. J. β2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning. Neurobiol. Learn. Mem. 89, 106–113 (2008).
Lena, C. et al. Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons. Proc. Natl Acad. Sci. USA 96, 12126–12131 (1999).
Champtiaux, N. et al. Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J. Neurosci. 22, 1208–1217, (2002).
Fonck, C. et al. Demonstration of functional α4-containing nicotinic receptors in the medial habenula. Neuropharmacology 56, 247–253 (2009).
Maisonneuve, I. M. & Glick, S. D. Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment. Pharmacol. Biochem. Behav. 75, 607–618 (2003).
Matsumoto, M. & Hikosaka, O. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 447, 1111–1115 (2007).
Hikosaka, O., Sesack, S. R., Lecourtier, L. & Shepard, P. D. Habenula: crossroad between the basal ganglia and the limbic system. J. Neurosci. 28, 11825–11829 (2008).
National Cancer Institute. Phenotypes and endophenotypes: foundations for genetic studies of nicotine use and dependence. NCI Tobacco Control Monograph 20 (eds Swan, G. E. et al.) (2009).
Saccone, S. F. et al. Supplementing high-density SNP microarrays for additional coverage of disease-related genes: addiction as a paradigm. PLoS ONE 4, e5225 (2009).
Li, M. D. & Burmeister, M. New insights into the genetics of addiction. Nature Rev. Genet. 10, 225–231 (2009).
Changeux, J. & Dehaene, S. in Learning and Memory: A Comprehensive Reference (ed. Byrne, J.) Vol. 1, 729–758 (Elsevier, Oxford, 2008). A general review about the global neuronal workspace hypothesis of consciousness.
Sergent, C. & Dehaene, S. Neural processes underlying conscious perception: experimental findings and a global neuronal workspace framework. J. Physiol. Paris 98, 374–384 (2004).
Sergent, C., Baillet, S. & Dehaene, S. Timing of the brain events underlying access to consciousness during the attentional blink. Nature Neurosci. 8, 1391–1400 (2005).
Del Cul, A., Baillet, S. & Dehaene, S. Brain dynamics underlying the nonlinear threshold for access to consciousness. PLoS Biol. 5, e260 (2007).
Naqvi, N. H., Rudrauf, D., Damasio, H. & Bechara, A. Damage to the insula disrupts addiction to cigarette smoking. Science 315, 531–534 (2007).
Contreras, M., Ceric, F. & Torrealba, F. Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium. Science 318, 655–658 (2007).
Miller, E. K. The prefrontal cortex and cognitive control. Nature Rev. Neurosci. 1, 59–65 (2000).
Amiaz, R., Levy, D., Vainiger, D., Grunhaus, L. & Zangen, A. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction 104, 653–660 (2009).
Lim, K. O., Choi, S. J., Pomara, N., Wolkin, A. & Rotrosen, J. P. Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol. Psychiatry 51, 890–895 (2002).
Liu, H. et al. Disrupted white matter integrity in heroin dependence: a controlled study utilizing diffusion tensor imaging. Am. J. Drug Alcohol Abuse 34, 562–575 (2008).
Jacobsen, L. K. et al. Prenatal and adolescent exposure to tobacco smoke modulates the development of white matter microstructure. J. Neurosci. 27, 13491–13498 (2007). This study demonstrates the long-term consequences of tobacco smoking on white matter organization.
Gil, Z., Connors, B. W. & Amitai, Y. Differential regulation of neocortical synapses by neuromodulators and activity. Neuron 19, 679–686 (1997).
Lena, C., Changeux, J. P. & Mulle, C. Evidence for “preterminal” nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J. Neurosci. 13, 2680–2688 (1993).
Kawai, H., Lazar, R. & Metherate, R. Nicotinic control of axon excitability regulates thalamocortical transmission. Nature Neurosci. 10, 1168–1175 (2007).
Hollander, J. A., Lu, Q., Cameron, M. D., Kamenecka, T. M. & Kenny, P. J. Insular hypocretin transmission regulates nicotine reward. Proc. Natl Acad. Sci. USA 105, 19480–19485 (2008).
Paterson, N. E., Semenova, S. & Markou, A. The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat. Psychopharmacology (Berl.) 198, 351–362 (2008).
Changeux, J. P. & Taly, A. Nicotinic receptors, allosteric proteins and medicine. Trends Mol. Med. 14, 93–102 (2008).
Balfour, D. J., Wright, A. E., Benwell, M. E. & Birrell, C. E. The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behav. Brain. Res. 113, 73–83 (2000).
Balfour, D. J. The neuronal pathways mediating the behavioral and addictive properties of nicotine. Handb. Exp. Pharmacol. 192, 209–233 (2009).
Di Chiara, G. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur. J. Pharmacol. 393, 295–314 (2000).
Picciotto, M. R. & Corrigall, W. A. Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. J. Neurosci. 22, 3338–3341 (2002).
Maskos, U. The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology. Br. J. Pharmacol. 153, S438–S445 (2008).
Acknowledgements
I thank I. Damaj, P. Faure, G. Koob, U. Maskos and S. Tolu for helpful comments. The work was supported by CNRS URA 2182 and by the IPSEN foundation (neuronal plasticity award).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
Jean-Pierre Changeux received the IPSEN foundation award Neuronal Plasticity 2008 specifically on the theme of this Review. He has also been a consultant for Servier Laboratories on the design of nicotinic drugs in 2009 and 2010.
Supplementary information
Supplementary Information S1 (Box)
WGenetic vulnerability to nicotine addiction (PDF 261 kb)
Related links
Glossary
- Resident–intruder test
-
A test for social interaction and aggressive behaviour in rodents. An unfamiliar mouse (the 'intruder') is introduced into the cage of a mouse that has been kept isolated in its 'resident' cage for several months.
- Navigation
-
Spontaneous locomotor behaviour characterized by large movements at fast speed, aimed at acquiring general information about the environment.
- Exploration
-
Spontaneous locomotor behaviour characterized by small and slow movements, enabling more precise investigation of the environment.
- Nigrostriatal pathway
-
The dopaminergic pathway from the substantia nigra to the striatum, which is associated with motor control.
- Mesolimbic pathway
-
The dopaminergic pathway from the ventral tegmental area to the nucleus accumbens and limbic areas, which is associated with reward processing.
- Fear conditioning
-
A form of learning in which an aversive stimulus (for example, an electric shock) is associated with a particular neutral context (for example, a room) or neutral stimulus (for example, a tone), resulting in the expression of fear responses to the originally neutral stimulus or context.
- Fractional anisotropy
-
A parameter in diffusion tensor imaging, which images brain structures by measuring the diffusion properties of water molecules. It provides information about the microstructural integrity of the white matter.
- Gene cluster
-
A group of neighbouring genes on a chromosome.
- Conditioned place preference task
-
A test for nicotine addiction potential in which the mouse receives a dose of nicotine in a distinct environment, after which the amount of time the mouse spends in that environment is assessed.
- Nicotine discrimination
-
The ability of mice to discriminate nicotine from saline using a two-bar operant procedure with a tandem schedule of food reinforcement.
- Spike timing-dependent plasticity
-
A form of plasticity that results from functional changes in neurons and/or synapses and that depends on the precise timing of action potentials in connected neurons.
- Giant depolarizing potentials
-
An early type of electrical activity that arises in the course of development and is probably due to excitatory actions of GABA.
- Intracranial electrical self-stimulation
-
A procedure in which rats work (for example, pressing a lever) to obtain rewarding electrical self-stimulation through an electrode implanted in the brain's reward system. It is used to measure the sensitivity of the brain reward system in vivo.
- Contextual fear conditioning
-
A behavourial test in which an aversive stimulus is given to an animal in a conditioning chamber, such that the fear response can subsequently be elicited in the conditioning chamber in the absence of the aversive stimulus.
- Conditioned place aversion
-
A form of classical Pavlovian conditioning in which an animal learns to avoid a compartment that was previously paired with an aversive stimulus; for example, the aversive stimulus can be the negative affective state caused by nicotine withdrawal.
Rights and permissions
About this article
Cite this article
Changeux, JP. Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nat Rev Neurosci 11, 389–401 (2010). https://doi.org/10.1038/nrn2849
Issue Date:
DOI: https://doi.org/10.1038/nrn2849
This article is cited by
-
Review: Nicotinic acetylcholine receptors to regulate important brain activity—what occurs at the molecular level?
Cognitive Neurodynamics (2023)
-
Systemic injection of nicotinic acetylcholine receptor antagonist mecamylamine affects licking, eyelid size, and locomotor and autonomic activities but not temporal prediction in male mice
Molecular Brain (2022)
-
Nicotinic receptors promote susceptibility to social stress in female mice linked with neuroadaptations within VTA dopamine neurons
Neuropsychopharmacology (2022)
-
A novel effect of PDLIM5 in α7 nicotinic acetylcholine receptor upregulation and surface expression
Cellular and Molecular Life Sciences (2022)
-
Lacidipine Attenuates Symptoms of Nicotine Withdrawal in Mice
Neurotoxicity Research (2021)